Work

Figure S3 from 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors

Year: 2024

Type: other

Abstract: S3. EMP2 expression in cancer cell lines. A. Based on public repositories, upregulation of EMP2 occurs in breast, brain, and ovarian cancers, while downregulation is predicted in hematopoietic cancers. B, C. Flow cytometry studies using a panel of human (B) and murine (C) cancer cell lines to validate differential EMP2 expression.

DOI: 10.1158/1535-7163.25964920

Authors: Ann M. Chan, Tove Olafsen, Jessica Tsui, Felix B. Salazar, Brian Aguirre, Kirstin A. Zettlitz, Michael Condro, Anna M. Wu, Jonathan Braun, Lynn K. Gordon, Negin Ashki, Julian Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4399345727

Cites:

Cited by:

Related to: 10